XPHOZAH Trademark

Trademark Overview

On Tuesday, September 1, 2020, a trademark application was filed for XPHOZAH with the United States Patent and Trademark Office. The USPTO has given the XPHOZAH trademark a serial number of 90151963. The federal status of this trademark filing is REGISTERED as of Tuesday, May 11, 2021. This trademark is owned by Ardelyx, Inc.. The XPHOZAH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of hyperphosphatemia
xphozah

General Information

Serial Number90151963
Word MarkXPHOZAH
Filing DateTuesday, September 1, 2020
Status700 - REGISTERED
Status DateTuesday, May 11, 2021
Registration Number6350274
Registration DateTuesday, May 11, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of hyperphosphatemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 6, 2020
Primary Code005
First Use Anywhere DateThursday, February 25, 2021
First Use In Commerce DateThursday, February 25, 2021

Trademark Owner History

Party NameArdelyx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameArdelyx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFremont, CA 94555
Party NameArdelyx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFremont, CA 94555

Trademark Events

Event DateEvent Description
Friday, September 4, 2020NEW APPLICATION ENTERED
Tuesday, October 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 15, 2020ASSIGNED TO EXAMINER
Thursday, October 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 26, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, March 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 26, 2021USE AMENDMENT FILED
Friday, March 19, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 6, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 7, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 11, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 13, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 13, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 13, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 13, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 13, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

xphozah hyperphosphatemia prevention treatment preparations pharmaceutical